Clotting Factor Market - Global Outlook and Forecast 2022-2028

January 2022 | 74 pages | ID: CF2490D17B04EN
Market Monitor Global

Abstracts

Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels.

This report contains market size and forecasts of Clotting Factor in Global, including the following market information:

Global Clotting Factor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Clotting Factor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Clotting Factor I Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Clotting Factor include Amgen, Novartis, Baxter, Britannia, Capricor, CSL Behring, GlaxoSmithKline, Grifol and Eli Lilly. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clotting Factor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clotting Factor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Clotting Factor Market Segment Percentages, by Type, 2021 (%)

• Clotting Factor I
• Clotting Factor II
• Clotting Factor III
• Clotting Factor IV
• Others

Global Clotting Factor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Clotting Factor Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global Clotting Factor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Clotting Factor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Clotting Factor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Clotting Factor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Novartis
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifol
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clotting Factor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clotting Factor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLOTTING FACTOR OVERALL MARKET SIZE

2.1 Global Clotting Factor Market Size: 2021 VS 2028
2.2 Global Clotting Factor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Clotting Factor Players in Global Market
3.2 Top Global Clotting Factor Companies Ranked by Revenue
3.3 Global Clotting Factor Revenue by Companies
3.4 Top 3 and Top 5 Clotting Factor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Clotting Factor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clotting Factor Players in Global Market
  3.6.1 List of Global Tier 1 Clotting Factor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Clotting Factor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Clotting Factor Market Size Markets, 2021 & 2028
  4.1.2 Clotting Factor I
  4.1.3 Clotting Factor II
  4.1.4 Clotting Factor III
  4.1.5 Clotting Factor IV
  4.1.6 Others
4.2 By Type - Global Clotting Factor Revenue & Forecasts
  4.2.1 By Type - Global Clotting Factor Revenue, 2017-2022
  4.2.2 By Type - Global Clotting Factor Revenue, 2023-2028
  4.2.3 By Type - Global Clotting Factor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Clotting Factor Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Clotting Factor Revenue & Forecasts
  5.2.1 By Application - Global Clotting Factor Revenue, 2017-2022
  5.2.2 By Application - Global Clotting Factor Revenue, 2023-2028
  5.2.3 By Application - Global Clotting Factor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Clotting Factor Market Size, 2021 & 2028
6.2 By Region - Global Clotting Factor Revenue & Forecasts
  6.2.1 By Region - Global Clotting Factor Revenue, 2017-2022
  6.2.2 By Region - Global Clotting Factor Revenue, 2023-2028
  6.2.3 By Region - Global Clotting Factor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Clotting Factor Revenue, 2017-2028
  6.3.2 US Clotting Factor Market Size, 2017-2028
  6.3.3 Canada Clotting Factor Market Size, 2017-2028
  6.3.4 Mexico Clotting Factor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Clotting Factor Revenue, 2017-2028
  6.4.2 Germany Clotting Factor Market Size, 2017-2028
  6.4.3 France Clotting Factor Market Size, 2017-2028
  6.4.4 U.K. Clotting Factor Market Size, 2017-2028
  6.4.5 Italy Clotting Factor Market Size, 2017-2028
  6.4.6 Russia Clotting Factor Market Size, 2017-2028
  6.4.7 Nordic Countries Clotting Factor Market Size, 2017-2028
  6.4.8 Benelux Clotting Factor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Clotting Factor Revenue, 2017-2028
  6.5.2 China Clotting Factor Market Size, 2017-2028
  6.5.3 Japan Clotting Factor Market Size, 2017-2028
  6.5.4 South Korea Clotting Factor Market Size, 2017-2028
  6.5.5 Southeast Asia Clotting Factor Market Size, 2017-2028
  6.5.6 India Clotting Factor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Clotting Factor Revenue, 2017-2028
  6.6.2 Brazil Clotting Factor Market Size, 2017-2028
  6.6.3 Argentina Clotting Factor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Clotting Factor Revenue, 2017-2028
  6.7.2 Turkey Clotting Factor Market Size, 2017-2028
  6.7.3 Israel Clotting Factor Market Size, 2017-2028
  6.7.4 Saudi Arabia Clotting Factor Market Size, 2017-2028
  6.7.5 UAE Clotting Factor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Clotting Factor Major Product Offerings
  7.1.4 Amgen Clotting Factor Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Clotting Factor Major Product Offerings
  7.2.4 Novartis Clotting Factor Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Baxter
  7.3.1 Baxter Corporate Summary
  7.3.2 Baxter Business Overview
  7.3.3 Baxter Clotting Factor Major Product Offerings
  7.3.4 Baxter Clotting Factor Revenue in Global Market (2017-2022)
  7.3.5 Baxter Key News
7.4 Britannia
  7.4.1 Britannia Corporate Summary
  7.4.2 Britannia Business Overview
  7.4.3 Britannia Clotting Factor Major Product Offerings
  7.4.4 Britannia Clotting Factor Revenue in Global Market (2017-2022)
  7.4.5 Britannia Key News
7.5 Capricor
  7.5.1 Capricor Corporate Summary
  7.5.2 Capricor Business Overview
  7.5.3 Capricor Clotting Factor Major Product Offerings
  7.5.4 Capricor Clotting Factor Revenue in Global Market (2017-2022)
  7.5.5 Capricor Key News
7.6 CSL Behring
  7.6.1 CSL Behring Corporate Summary
  7.6.2 CSL Behring Business Overview
  7.6.3 CSL Behring Clotting Factor Major Product Offerings
  7.6.4 CSL Behring Clotting Factor Revenue in Global Market (2017-2022)
  7.6.5 CSL Behring Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Clotting Factor Major Product Offerings
  7.7.4 GlaxoSmithKline Clotting Factor Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Grifol
  7.8.1 Grifol Corporate Summary
  7.8.2 Grifol Business Overview
  7.8.3 Grifol Clotting Factor Major Product Offerings
  7.8.4 Grifol Clotting Factor Revenue in Global Market (2017-2022)
  7.8.5 Grifol Key News
7.9 Eli Lilly
  7.9.1 Eli Lilly Corporate Summary
  7.9.2 Eli Lilly Business Overview
  7.9.3 Eli Lilly Clotting Factor Major Product Offerings
  7.9.4 Eli Lilly Clotting Factor Revenue in Global Market (2017-2022)
  7.9.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Clotting Factor Market Opportunities & Trends in Global Market
Table 2. Clotting Factor Market Drivers in Global Market
Table 3. Clotting Factor Market Restraints in Global Market
Table 4. Key Players of Clotting Factor in Global Market
Table 5. Top Clotting Factor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Clotting Factor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Clotting Factor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Clotting Factor Product Type
Table 9. List of Global Tier 1 Clotting Factor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clotting Factor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Clotting Factor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Clotting Factor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Clotting Factor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Clotting Factor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Clotting Factor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Clotting Factor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Clotting Factor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Clotting Factor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Clotting Factor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Clotting Factor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Clotting Factor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Clotting Factor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Clotting Factor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Clotting Factor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Clotting Factor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Clotting Factor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Clotting Factor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Clotting Factor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Clotting Factor Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Clotting Factor Product Offerings
Table 32. Amgen Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Clotting Factor Product Offerings
Table 35. Novartis Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 36. Baxter Corporate Summary
Table 37. Baxter Clotting Factor Product Offerings
Table 38. Baxter Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 39. Britannia Corporate Summary
Table 40. Britannia Clotting Factor Product Offerings
Table 41. Britannia Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 42. Capricor Corporate Summary
Table 43. Capricor Clotting Factor Product Offerings
Table 44. Capricor Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 45. CSL Behring Corporate Summary
Table 46. CSL Behring Clotting Factor Product Offerings
Table 47. CSL Behring Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Clotting Factor Product Offerings
Table 50. GlaxoSmithKline Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 51. Grifol Corporate Summary
Table 52. Grifol Clotting Factor Product Offerings
Table 53. Grifol Clotting Factor Revenue (US$, Mn), (2017-2022)
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Clotting Factor Product Offerings
Table 56. Eli Lilly Clotting Factor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Clotting Factor Segment by Type in 2021
Figure 2. Clotting Factor Segment by Application in 2021
Figure 3. Global Clotting Factor Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Clotting Factor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Clotting Factor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clotting Factor Revenue in 2021
Figure 8. By Type - Global Clotting Factor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Clotting Factor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Clotting Factor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Clotting Factor Revenue Market Share, 2017-2028
Figure 12. US Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Clotting Factor Revenue Market Share, 2017-2028
Figure 16. Germany Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 17. France Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Clotting Factor Revenue Market Share, 2017-2028
Figure 24. China Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 28. India Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Clotting Factor Revenue Market Share, 2017-2028
Figure 30. Brazil Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Clotting Factor Revenue Market Share, 2017-2028
Figure 33. Turkey Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Clotting Factor Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Baxter Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Britannia Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Capricor Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CSL Behring Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Grifol Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eli Lilly Clotting Factor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)